(R)-TERT-BUTYL (1-((BENZYLOXY)AMINO)-3-HYDROXY-3-METHYL-1-OXOBUTAN-2-YL)CARBAMATE, 95.0%, 250mg

3-(3,5-Dichlorophenyl)piperidine, 97%, 250mg

DBD-NCS [=4-(N,N-Dimethylaminosulfonyl)-7-isothiocyanato-2,1,3-benzoxadiazole] [for HPLC Labeling and Edman Degradation]100mg

2-(4-Bromobenzyl)-4-methyl-2H-pyrazol-3-ylamine, >95%, 1g

(4-Methyl-2-thioxo-2,3-dihydro-thiazol-5-yl)-acetic acid, 97.0%, 25g

Ethyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate, 97%, 1g

1,2-BIS((2R,5R)-2,5-DIISOPROPYLPHOSPHOLAN-1-YL)ETHANE, 95%, 250mg

Isopropylidene-adenosine-5-carboxylic acid, 98%, 100mg

Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 5g

2,3-Dihydro-2-oxo-1,3-benzooxazol-6-sulfonyl chloride, 95.0%, 5g

2-Bromomethyl-6-methoxy-benzo[b]thiophene, 95.0%, 1g

1-[4-(Trifluoromethyl)pyrimid-2-yl]homopiperazine, 97.0%, 250mg

3-Bromopyridazine, 95.0%, 5g